News
ICCC
5.03
+0.20%
0.01
Weekly Report: what happened at ICCC last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at ICCC last week (0408-0412)?
Weekly Report · 04/15 11:14
IMMUCELL CORP - ENTERED INTO AT MARKET OFFERING AGREEMENT WITH CRAIG-HALLUM CAPITAL GROUP LLC
Reuters · 04/09 21:20
IMMUCELL CORP - FIRST AMENDMENT, AMENDS FAME LOAN DEAL TO REMOVE ANY RESTRICTIONS ON CO’S ABILITY TO ISSUE EQUITY SECURITIES, PERMITTING SALES
Reuters · 04/09 21:20
IMMUCELL CORP -PURSUANT TO AGREEMENT, CO MAY OFFER AND SELL, FROM TIME TO TIME, UP TO $11 MLN OF SHARES OF ITS COMMON STOCK
Reuters · 04/09 21:20
IMMUCELL CORP - ON APRIL 8, CO ENTERED INTO AMENDMENT TO CO’S ECONOMIC RECOVERY LOAN PROGRAM LOAN AGREEMENT, DATED JULY 17, 2023
Reuters · 04/09 21:20
ImmuCell reports preliminary Q1 sales, stock climbs 7%
ImmuCell reports preliminary Q1 2024 sales jumped 111% year-over-year to $7.3M. The animal health company's stock climbs 7% in post-market trading. The company expects a response from the FDA in May for its cow health product Re-Train.
Seeking Alpha · 04/09 20:47
12 Health Care Stocks Moving In Tuesday's After-Market Session
Jaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. ATyr Pharma shares rose 10.45% and Corvus Pharma shares increased by 7.36%. Apyx Medical shares declined by 6.1% during the session.
Benzinga · 04/09 20:31
ImmuCell Reports Preliminary, Unaudited Sales Results For Q1 2024 Of $7.3M, Up 111% Y/Y
Benzinga · 04/09 20:09
IMMUCELL ANNOUNCES PRELIMINARY, UNAUDITED SALES RESULTS FOR Q1 2024
Reuters · 04/09 20:05
Weekly Report: what happened at ICCC last week (0401-0405)?
Weekly Report · 04/08 11:19
ImmuCell files for $20M mixed shelf offering
Seeking Alpha · 04/02 14:38
BRIEF-Immucell Corp Says From Time To Time, It May Offer Up To $20 Million Of Common Stock, Warrants And Subscription Rights, In One Or More Transactions
Immucell Corp says it may offer up to $20 million of common stock, warrants and subscription rights in one or more transactions. Immucell says it will offer the stock in a variety of ways. The company says it is in talks to sell the stock.
Reuters · 04/01 22:27
IMMUCELL CORP - FROM TIME TO TIME, MAY OFFER UP TO $20 MLN OF COMMON STOCK, WARRANTS AND SUBSCRIPTION RIGHTS, IN ONE OR MORE TRANSACTIONS
Reuters · 04/01 21:14
Weekly Report: what happened at ICCC last week (0325-0329)?
Weekly Report · 04/01 11:17
Weekly Report: what happened at ICCC last week (0318-0322)?
Weekly Report · 03/25 11:20
Weekly Report: what happened at ICCC last week (0311-0315)?
Weekly Report · 03/18 11:18
Weekly Report: what happened at ICCC last week (0304-0308)?
Weekly Report · 03/11 11:15
Weekly Report: what happened at ICCC last week (0226-0301)?
Weekly Report · 03/04 11:18
Immucell: Current report
Press release · 02/27 22:38
More
Webull provides a variety of real-time ICCC stock news. You can receive the latest news about Immucell through multiple platforms. This information may help you make smarter investment decisions.
About ICCC
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows. The First Defense product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. Its product line extension, Tri-Shield First Defense, is the first calf-level, passive antibody product providing Immediate Immunity against each of the three causes of calf scours (E. coli, coronavirus, and rotavirus).